Long-Term Changes in Sarcopenia and Body Composition in Diabetes Patients with and without Charcot Osteoarthropathy

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Long-Term Changes in Sarcopenia and Body Composition in Diabetes Patients with and without Charcot Osteoarthropathy. / Sørensen, Michael Zaucha; Jansen, Rasmus Bo; Christensen, Tomas Møller; Holstein, Per E.; Svendsen, Ole Lander.

In: Journal of Diabetes Research, Vol. 2022, 3142307, 2022.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Sørensen, MZ, Jansen, RB, Christensen, TM, Holstein, PE & Svendsen, OL 2022, 'Long-Term Changes in Sarcopenia and Body Composition in Diabetes Patients with and without Charcot Osteoarthropathy', Journal of Diabetes Research, vol. 2022, 3142307. https://doi.org/10.1155/2022/3142307

APA

Sørensen, M. Z., Jansen, R. B., Christensen, T. M., Holstein, P. E., & Svendsen, O. L. (2022). Long-Term Changes in Sarcopenia and Body Composition in Diabetes Patients with and without Charcot Osteoarthropathy. Journal of Diabetes Research, 2022, [3142307]. https://doi.org/10.1155/2022/3142307

Vancouver

Sørensen MZ, Jansen RB, Christensen TM, Holstein PE, Svendsen OL. Long-Term Changes in Sarcopenia and Body Composition in Diabetes Patients with and without Charcot Osteoarthropathy. Journal of Diabetes Research. 2022;2022. 3142307. https://doi.org/10.1155/2022/3142307

Author

Sørensen, Michael Zaucha ; Jansen, Rasmus Bo ; Christensen, Tomas Møller ; Holstein, Per E. ; Svendsen, Ole Lander. / Long-Term Changes in Sarcopenia and Body Composition in Diabetes Patients with and without Charcot Osteoarthropathy. In: Journal of Diabetes Research. 2022 ; Vol. 2022.

Bibtex

@article{7e7cf9252eb040ebbb22b696f9d15d90,
title = "Long-Term Changes in Sarcopenia and Body Composition in Diabetes Patients with and without Charcot Osteoarthropathy",
abstract = "Background. Charcot osteoarthropathy of the foot (COA) can currently only be treated using prolonged periods of immobilization of the affected extremity. Therefore, the hypothesis is that COA leads to altered body composition and increased sarcopenia. Objective. To investigate the changes over several years in sarcopenia, body composition, and fat distribution in diabetes patients with previous COA compared to diabetes patients without previous COA. Methods. Prospective observational clinical study. Twenty-one subjects were included and had two DXA scans done with mean 8.6-year intervals to compare changes in lean mass and fat distribution. The lean mass of limbs was used as an estimate of appendicular lean mass (aLM). Fat mass and aLM were then used to detect sarcopenic individuals using different methods. Results and Conclusions. As compared to baseline, both groups had significant loss of lean mass, and diabetics without COA had significant gain of total fat percentage. No statistically different prevalence of sarcopenia between the groups could be established. Likewise, no difference was found in total lean and fat mass changes. None of the groups had statistically significant changes of android fat distribution. As compared with published data on sarcopenia, people with diabetes might be more prone to sarcopenia than healthy individuals. ",
author = "S{\o}rensen, {Michael Zaucha} and Jansen, {Rasmus Bo} and Christensen, {Tomas M{\o}ller} and Holstein, {Per E.} and Svendsen, {Ole Lander}",
note = "Publisher Copyright: {\textcopyright} 2022 Michael Zaucha S{\o}rensen et al.",
year = "2022",
doi = "10.1155/2022/3142307",
language = "English",
volume = "2022",
journal = "Journal of Diabetes Research",
issn = "2314-6745",
publisher = "Hindawi Publishing Corporation",

}

RIS

TY - JOUR

T1 - Long-Term Changes in Sarcopenia and Body Composition in Diabetes Patients with and without Charcot Osteoarthropathy

AU - Sørensen, Michael Zaucha

AU - Jansen, Rasmus Bo

AU - Christensen, Tomas Møller

AU - Holstein, Per E.

AU - Svendsen, Ole Lander

N1 - Publisher Copyright: © 2022 Michael Zaucha Sørensen et al.

PY - 2022

Y1 - 2022

N2 - Background. Charcot osteoarthropathy of the foot (COA) can currently only be treated using prolonged periods of immobilization of the affected extremity. Therefore, the hypothesis is that COA leads to altered body composition and increased sarcopenia. Objective. To investigate the changes over several years in sarcopenia, body composition, and fat distribution in diabetes patients with previous COA compared to diabetes patients without previous COA. Methods. Prospective observational clinical study. Twenty-one subjects were included and had two DXA scans done with mean 8.6-year intervals to compare changes in lean mass and fat distribution. The lean mass of limbs was used as an estimate of appendicular lean mass (aLM). Fat mass and aLM were then used to detect sarcopenic individuals using different methods. Results and Conclusions. As compared to baseline, both groups had significant loss of lean mass, and diabetics without COA had significant gain of total fat percentage. No statistically different prevalence of sarcopenia between the groups could be established. Likewise, no difference was found in total lean and fat mass changes. None of the groups had statistically significant changes of android fat distribution. As compared with published data on sarcopenia, people with diabetes might be more prone to sarcopenia than healthy individuals.

AB - Background. Charcot osteoarthropathy of the foot (COA) can currently only be treated using prolonged periods of immobilization of the affected extremity. Therefore, the hypothesis is that COA leads to altered body composition and increased sarcopenia. Objective. To investigate the changes over several years in sarcopenia, body composition, and fat distribution in diabetes patients with previous COA compared to diabetes patients without previous COA. Methods. Prospective observational clinical study. Twenty-one subjects were included and had two DXA scans done with mean 8.6-year intervals to compare changes in lean mass and fat distribution. The lean mass of limbs was used as an estimate of appendicular lean mass (aLM). Fat mass and aLM were then used to detect sarcopenic individuals using different methods. Results and Conclusions. As compared to baseline, both groups had significant loss of lean mass, and diabetics without COA had significant gain of total fat percentage. No statistically different prevalence of sarcopenia between the groups could be established. Likewise, no difference was found in total lean and fat mass changes. None of the groups had statistically significant changes of android fat distribution. As compared with published data on sarcopenia, people with diabetes might be more prone to sarcopenia than healthy individuals.

UR - http://www.scopus.com/inward/record.url?scp=85125594781&partnerID=8YFLogxK

U2 - 10.1155/2022/3142307

DO - 10.1155/2022/3142307

M3 - Journal article

C2 - 35224105

AN - SCOPUS:85125594781

VL - 2022

JO - Journal of Diabetes Research

JF - Journal of Diabetes Research

SN - 2314-6745

M1 - 3142307

ER -

ID: 328890865